quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:33:40·2d
ANALYSTRating
First Tracks Biotherapeutics Inc. logo

UBS initiated coverage on First Tracks Biotherapeutics with a new price target

TRAX· First Tracks Biotherapeutics Inc.
Health Care
Original source

Companies

  • TRAX
    First Tracks Biotherapeutics Inc.
    Health Care

Recent analyst ratings

  • Apr 23UpdateAnalyst$31.00
  • Apr 22UpdateBarclays$40.00
  • Apr 21UpdateUBS$45.00

Related

  • INSIDER5h
    SEC Form 3 filed by new insider Tamboli Ajim
  • INSIDER5h
    SEC Form 4 filed by Chief Financial Officer Tamboli Ajim
  • ANALYST16h
    Analyst initiated coverage on First Tracks Biotherapeutics with a new price target
  • SEC1d
    SEC Form SCHEDULE 13G filed by First Tracks Biotherapeutics Inc.
  • INSIDER1d
    SEC Form 4 filed by Ecor1 Capital, Llc
  • INSIDER1d
    SEC Form 3 filed by new insider Ecor1 Capital, Llc
  • INSIDER1d
    SEC Form 3 filed by new insider Stone Benjamin
  • INSIDER1d
    SEC Form 4 filed by Ware J. Anthony
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022